chr18-23857967-G-C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_198129.4(LAMA3):​c.4260G>C​(p.Gly1420Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.563 in 1,613,780 control chromosomes in the GnomAD database, including 268,765 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. G1420G) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.47 ( 19255 hom., cov: 32)
Exomes 𝑓: 0.57 ( 249510 hom. )

Consequence

LAMA3
NM_198129.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 0.294

Publications

15 publications found
Variant links:
Genes affected
LAMA3 (HGNC:6483): (laminin subunit alpha 3) The protein encoded by this gene belongs to the laminin family of secreted molecules. Laminins are heterotrimeric molecules that consist of alpha, beta, and gamma subunits that assemble through a coiled-coil domain. Laminins are essential for formation and function of the basement membrane and have additional functions in regulating cell migration and mechanical signal transduction. This gene encodes an alpha subunit and is responsive to several epithelial-mesenchymal regulators including keratinocyte growth factor, epidermal growth factor and insulin-like growth factor. Mutations in this gene have been identified as the cause of Herlitz type junctional epidermolysis bullosa and laryngoonychocutaneous syndrome. Alternative splicing and alternative promoter usage result in multiple transcript variants. [provided by RefSeq, Dec 2014]
LAMA3 Gene-Disease associations (from GenCC):
  • junctional epidermolysis bullosa
    Inheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women’s Health
  • laryngo-onycho-cutaneous syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp
  • junctional epidermolysis bullosa Herlitz type
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet
  • junctional epidermolysis bullosa, non-Herlitz type
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
  • generalized junctional epidermolysis bullosa non-Herlitz type
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 18-23857967-G-C is Benign according to our data. Variant chr18-23857967-G-C is described in ClinVar as Benign. ClinVar VariationId is 403026.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.294 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.611 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_198129.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LAMA3
NM_198129.4
MANE Select
c.4260G>Cp.Gly1420Gly
synonymous
Exon 33 of 75NP_937762.2Q16787-2
LAMA3
NM_001127717.4
c.4260G>Cp.Gly1420Gly
synonymous
Exon 33 of 74NP_001121189.2A0A0A0MSA0

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LAMA3
ENST00000313654.14
TSL:1 MANE Select
c.4260G>Cp.Gly1420Gly
synonymous
Exon 33 of 75ENSP00000324532.8Q16787-2
LAMA3
ENST00000399516.7
TSL:1
c.4260G>Cp.Gly1420Gly
synonymous
Exon 33 of 74ENSP00000382432.2Q16787-3
LAMA3
ENST00000649721.1
c.1152G>Cp.Gly384Gly
synonymous
Exon 8 of 48ENSP00000497885.1A0A3B3ITG1

Frequencies

GnomAD3 genomes
AF:
0.475
AC:
72109
AN:
151944
Hom.:
19256
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.258
Gnomad AMI
AF:
0.672
Gnomad AMR
AF:
0.451
Gnomad ASJ
AF:
0.664
Gnomad EAS
AF:
0.161
Gnomad SAS
AF:
0.397
Gnomad FIN
AF:
0.548
Gnomad MID
AF:
0.567
Gnomad NFE
AF:
0.616
Gnomad OTH
AF:
0.513
GnomAD2 exomes
AF:
0.494
AC:
123290
AN:
249472
AF XY:
0.504
show subpopulations
Gnomad AFR exome
AF:
0.247
Gnomad AMR exome
AF:
0.353
Gnomad ASJ exome
AF:
0.664
Gnomad EAS exome
AF:
0.162
Gnomad FIN exome
AF:
0.554
Gnomad NFE exome
AF:
0.616
Gnomad OTH exome
AF:
0.560
GnomAD4 exome
AF:
0.572
AC:
836700
AN:
1461716
Hom.:
249510
Cov.:
56
AF XY:
0.570
AC XY:
414610
AN XY:
727180
show subpopulations
African (AFR)
AF:
0.245
AC:
8212
AN:
33474
American (AMR)
AF:
0.366
AC:
16366
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.665
AC:
17379
AN:
26134
East Asian (EAS)
AF:
0.138
AC:
5480
AN:
39698
South Asian (SAS)
AF:
0.409
AC:
35300
AN:
86256
European-Finnish (FIN)
AF:
0.562
AC:
30010
AN:
53412
Middle Eastern (MID)
AF:
0.576
AC:
3323
AN:
5768
European-Non Finnish (NFE)
AF:
0.618
AC:
687082
AN:
1111866
Other (OTH)
AF:
0.556
AC:
33548
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
21092
42185
63277
84370
105462
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
17998
35996
53994
71992
89990
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.474
AC:
72119
AN:
152064
Hom.:
19255
Cov.:
32
AF XY:
0.466
AC XY:
34615
AN XY:
74338
show subpopulations
African (AFR)
AF:
0.258
AC:
10691
AN:
41468
American (AMR)
AF:
0.451
AC:
6890
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.664
AC:
2306
AN:
3472
East Asian (EAS)
AF:
0.162
AC:
837
AN:
5172
South Asian (SAS)
AF:
0.397
AC:
1914
AN:
4820
European-Finnish (FIN)
AF:
0.548
AC:
5784
AN:
10562
Middle Eastern (MID)
AF:
0.571
AC:
168
AN:
294
European-Non Finnish (NFE)
AF:
0.616
AC:
41846
AN:
67972
Other (OTH)
AF:
0.509
AC:
1070
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1770
3540
5311
7081
8851
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
634
1268
1902
2536
3170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.591
Hom.:
8846
Bravo
AF:
0.459
Asia WGS
AF:
0.278
AC:
967
AN:
3478
EpiCase
AF:
0.629
EpiControl
AF:
0.628

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not provided (3)
-
-
1
Junctional epidermolysis bullosa gravis of Herlitz (1)
-
-
1
Junctional epidermolysis bullosa, non-Herlitz type (1)
-
-
1
Laryngo-onycho-cutaneous syndrome (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.78
CADD
Benign
1.9
DANN
Benign
0.63
PhyloP100
0.29
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs867449; hg19: chr18-21437931; COSMIC: COSV58065064; API